LSB Industries heads into its Q2 earnings print — scheduled for July 30 — with options traders expressing the most bullish positioning seen in a year, even as short sellers quietly rebuild their bets.
The clearest signal this week is in options. The put/call ratio has collapsed to 0.057, more than two and a half standard deviations below its 20-day average of 0.108 — the lowest reading in at least 12 months. That gap is striking: call activity has swamped put volume to a degree that suggests some combination of outright bullish speculation and pre-earnings positioning on the upside. The move is all the more notable because it reversed sharply from recent norms — the PCR was running consistently around 0.12 through most of June and early July before dropping hard this week.
Short interest tells a more complicated story. Bears have rebuilt positions aggressively over the past month, with SI as a percentage of free float climbing to roughly 4.4% — up 75% from late June levels, when the short count was nearer 1.8 million shares. The week-on-week gain of 6.5% added another layer to the pressure. Yet the borrow market remains completely relaxed: availability runs at around 2,600% — meaning the shares available to lend are more than 26 times the existing short position — and cost to borrow is a negligible 0.51%. There is no squeeze pressure here. Shorts are rebuilding without friction, which positions look more like fresh conviction bets than a trapped holdover.
The Street has cooled on LXU in recent weeks. RBC Capital trimmed its target to $13 from $15 on July 17, maintaining a Sector Perform rating — a signal of fading confidence even if not outright bearishness. With the stock at $11.43, the analyst consensus mean of $13.70 implies roughly 20% upside, but both RBC and UBS are neutral, and Jefferies holds at Hold. Bulls point to the company's blue ammonia partnership with Lapis and the nitrogen market outlook, while bears flag nutrient price volatility and a concentrated, undiversified operational base. The EV/EBITDA multiple of 5.3x is undemanding, and the P/E of 9x suggests little premium is priced in. One factor score stands out: EPS surprise ranks in the 90th percentile, meaning LSB has consistently beaten estimates — a data point that may be giving options bulls confidence ahead of tomorrow.
Insider activity over the past few months adds an uncomfortable backdrop. Todd Boehly, the 10% shareholder, sold nearly 4.9 million shares in late March at $14.85 — a $72.6 million exit representing about 14% of the company. CEO Mark Behrman sold 250,000 shares in early March, and the CFO trimmed in the same window. Net insider selling over the past 90 days totals roughly $73.5 million. The stock is now trading well below those exit prices, which tells its own story about where insiders judged fair value at the time.
Earnings reactions in recent quarters have been uniformly negative. The last three prints each produced a day-one decline: -6.1% in July, -2.3% in May, and -2.8% in April — with the April print extending to -10.7% over the following five days. That pattern sets a cautious baseline against which the bullish options positioning looks like either a bold contrarian call or a misread of the setup.
The July 30 print is therefore less about whether LSB can beat on EPS — its surprise track record suggests it might — and more about whether management's commentary on nitrogen pricing and the blue ammonia timeline is strong enough to break a streak of three consecutive post-earnings selloffs.
See the live data behind this article on ORTEX.
Open LXU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
